HomeProductsBuilding BlocksOrganic Building BlocksAlkenyl Building BlocksCAS 923978-27-2
Chemical structure of CAS 923978-27-2

2-(2,6-Dimethyl-4-((1E)-3-(4-(methylthio)phenyl)-3-oxo-1-propen-1-yl)phenoxy)-2-methylpropanoic acid

CAS No.923978-27-2
MDL No.MFCD27987940
MFC22H24O4S
MW384.50
InChI KeyAFLFKFHDSCQHOL-IZZDOVSWSA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.923978-27-2
Product Name2-(2,6-Dimethyl-4-((1E)-3-(4-(methylthio)phenyl)-3-oxo-1-propen-1-yl)phenoxy)-2-methylpropanoic acid

Biological Targets

PPARA·PPARD

Associated Conditions

non-alcoholic fatty liver disease·sclerosing cholangitis·type 2 diabetes mellitus·primary biliary cirrhosis·non-alcoholic fatty liver·
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Correction: Elafibranor: First Approval.

Drugs • Vol. 84, Issue 9 • 2024
PMID: 39240532DOI: 10.1007/s40265-024-02088-3

Human hepatic in vitro models reveal distinct anti-NASH potencies of PPAR agonists.

Cell biology and toxicology • Vol. 37, Issue 2 • 2021
PMID: 32613381DOI: 10.1007/s10565-020-09544-2

New peroxisome proliferator-activated receptor agonists: potential treatments for atherogenic dyslipidemia and non-alcoholic fatty liver disease.

Expert opinion on pharmacotherapy • Vol. 15, Issue 4 • 2014
PMID: 24428677DOI: 10.1517/14656566.2014.876992

Dual peroxisome proliferator-activated receptor α/δ agonist GFT505 improves hepatic and peripheral insulin sensitivity in abdominally obese subjects.

Diabetes care • Vol. 36, Issue 10 • 2013
PMID: 23715754PMC: PMC3781493DOI: 10.2337/dc12-2012

Documentation